Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.
Press releases published on November 4, 2025
November 4, 2025
Ceribell Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 4, 2025
ImmuCell Announces Onboarding of New CEO and Related Management Changes
Indeterminate
GlobeNewswire
November 4, 2025
OnKure Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 4, 2025
OrthoPediatrics to Participate in Upcoming Conferences
Indeterminate
GlobeNewswire
November 4, 2025
Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace
Indeterminate
GlobeNewswire
November 4, 2025
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025
Indeterminate
GlobeNewswire
November 4, 2025
Clover Health Reports Third Quarter 2025 Results
Indeterminate
GlobeNewswire
November 4, 2025
Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
Indeterminate
GlobeNewswire
November 4, 2025
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 4, 2025
Ultragenyx Reports Third Quarter 2025 Financial Results and Corporate Update
Indeterminate
GlobeNewswire
November 4, 2025
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
Indeterminate
GlobeNewswire
November 4, 2025
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
Indeterminate
GlobeNewswire
November 4, 2025
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 4, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 4, 2025
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 4, 2025
Supernus Announces Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire